Skip to main content
NCBI home page
Archives of Disease in Childhood logoLink to Archives of Disease in Childhood
. 1990 Apr;65(4 Spec No):347–348. doi: 10.1136/adc.65.4_spec_no.347

Treatment of sepsis with IgG in very low birthweight infants.

A Whitelaw 1
PMCID: PMC1590143  PMID: 2186706

Full text

PDF
347

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Chirico G., Rondini G., Plebani A., Chiara A., Massa M., Ugazio A. G. Intravenous gammaglobulin therapy for prophylaxis of infection in high-risk neonates. J Pediatr. 1987 Mar;110(3):437–442. doi: 10.1016/s0022-3476(87)80514-0. [DOI] [PubMed] [Google Scholar]
  2. Didato M. A., Gioeli R., Priolisi A. The use of intravenous gamma-globulin for prevention of sepsis in pre-term infants. A controlled clinical trial. Helv Paediatr Acta. 1989 Feb;43(4):283–294. [PubMed] [Google Scholar]
  3. Gonzalez L. A., Hill H. R. The current status of intravenous gamma-globulin use in neonates. Pediatr Infect Dis J. 1989 May;8(5):315–322. [PubMed] [Google Scholar]
  4. Haque K. N., Zaidi M. H., Bahakim H. IgM-enriched intravenous immunoglobulin therapy in neonatal sepsis. Am J Dis Child. 1988 Dec;142(12):1293–1296. doi: 10.1001/archpedi.1988.02150120047038. [DOI] [PubMed] [Google Scholar]
  5. Haque K. N., Zaidi M. H., Haque S. K., Bahakim H., el-Hazmi M., el-Swailam M. Intravenous immunoglobulin for prevention of sepsis in preterm and low birth weight infants. Pediatr Infect Dis. 1986 Nov-Dec;5(6):622–625. doi: 10.1097/00006454-198611000-00004. [DOI] [PubMed] [Google Scholar]
  6. Harper T. E., Christensen R. D., Rothstein G., Hill H. R. Effect of intravenous immunoglobulin G on neutrophil kinetics during experimental group B streptococcal infection in neonatal rats. Rev Infect Dis. 1986 Jul-Aug;8 (Suppl 4):S401–S408. doi: 10.1093/clinids/8.supplement_4.s401. [DOI] [PubMed] [Google Scholar]
  7. Harper T. E., Christensen R. D., Rothstein G. The effect of administration of immunoglobulin to newborn rats with Escherichia coli sepsis and meningitis. Pediatr Res. 1987 Oct;22(4):455–460. doi: 10.1203/00006450-198710000-00019. [DOI] [PubMed] [Google Scholar]
  8. Montanaro A., Pirofsky B. Prolonged interval high-dose intravenous immunoglobulin in patients with primary immunodeficiency states. Am J Med. 1984 Mar 30;76(3A):67–72. doi: 10.1016/0002-9343(84)90322-x. [DOI] [PubMed] [Google Scholar]
  9. Noya F. J., Rench M. A., Garcia-Prats J. A., Jones T. M., Baker C. J. Disposition of an immunoglobulin intravenous preparation in very low birth weight neonates. J Pediatr. 1988 Feb;112(2):278–283. doi: 10.1016/s0022-3476(88)80070-2. [DOI] [PubMed] [Google Scholar]
  10. Raff H. V., Siscoe P. J., Wolff E. A., Maloney G., Shuford W. Human monoclonal antibodies to group B streptococcus. Reactivity and in vivo protection against multiple serotypes. J Exp Med. 1988 Sep 1;168(3):905–917. doi: 10.1084/jem.168.3.905. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Sidiropoulos D., Böhme U., von Muralt G., Morell A., Barandun S. Immunglobulinsubstitution bei der Behandlung der neonatalen Sepsis. Schweiz Med Wochenschr. 1981 Oct 31;111(44):1649–1655. [PubMed] [Google Scholar]
  12. Stabile A., Miceli Sopo S., Romanelli V., Pastore M., Pesaresi M. A. Intravenous immunoglobulin for prophylaxis of neonatal sepsis in premature infants. Arch Dis Child. 1988 Apr;63(4):441–443. doi: 10.1136/adc.63.4.441. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Wells M. A., Wittek A. E., Epstein J. S., Marcus-Sekura C., Daniel S., Tankersley D. L., Preston M. S., Quinnan G. V., Jr Inactivation and partition of human T-cell lymphotrophic virus, type III, during ethanol fractionation of plasma. Transfusion. 1986 Mar-Apr;26(2):210–213. doi: 10.1046/j.1537-2995.1986.26286152919.x. [DOI] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood are provided here courtesy of BMJ Publishing Group

RESOURCES